Charles Q Morris Receives Stock Award at Lava Therapeutics Nv (LVTX) — SEC Form 4, Feb 19, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
3 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Charles Q Morris CIK 0001489966 |
Officer
|
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy)F1 | $0.93 | 2025-02-13 | A - Award/Grant | 130,850 A | $0.00 | 2035-03-12 | 130,850 Common Shares | Direct |
Footnotes (1)
- F1
- The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date. Show more
Related filings at Lava Therapeutics Nv
Institutional Holders
13F holders · Sep 30, 2025
20
institutional managers reporting a position
Largest by reported value
- Shay Capital Llc $3.98M
- Redmile Group, Llc $3.24M
- Bml Capital Management, Llc $3.07M
5%+ Holders · 13D/G
3 filers
Other insiders at Lava Therapeutics Nv
GET /v1/forms/4/0001415889-25-004525
API docs
View Original SEC Filing